146 related articles for article (PubMed ID: 36847377)
61. Metastasis is an early event in mouse mammary carcinomas and is associated with cells bearing stem cell markers.
Weng D; Penzner JH; Song B; Koido S; Calderwood SK; Gong J
Breast Cancer Res; 2012 Jan; 14(1):R18. PubMed ID: 22277639
[TBL] [Abstract][Full Text] [Related]
62. Induction of mammary epithelial hyperplasias and mammary tumors in transgenic mice expressing a murine mammary tumor virus/activated c-src fusion gene.
Webster MA; Cardiff RD; Muller WJ
Proc Natl Acad Sci U S A; 1995 Aug; 92(17):7849-53. PubMed ID: 7544006
[TBL] [Abstract][Full Text] [Related]
63. Transgenes expressing the Wnt-1 and int-2 proto-oncogenes cooperate during mammary carcinogenesis in doubly transgenic mice.
Kwan H; Pecenka V; Tsukamoto A; Parslow TG; Guzman R; Lin TP; Muller WJ; Lee FS; Leder P; Varmus HE
Mol Cell Biol; 1992 Jan; 12(1):147-54. PubMed ID: 1530875
[TBL] [Abstract][Full Text] [Related]
64. Over-expression of erbB-2/neu is paralleled by inhibition of mouse-mammary-epithelial-cell differentiation and developmental apoptosis.
Lazar H; Baltzer A; Gimmi C; Marti A; Jaggi R
Int J Cancer; 2000 Feb; 85(4):578-83. PubMed ID: 10699933
[TBL] [Abstract][Full Text] [Related]
65. The biology of mammary transgenes: five rules.
Cardiff RD
J Mammary Gland Biol Neoplasia; 1996 Jan; 1(1):61-73. PubMed ID: 10887481
[TBL] [Abstract][Full Text] [Related]
66. Activation of phosphatidylinositol 3-kinase by membrane localization of p110alpha predisposes mammary glands to neoplastic transformation.
Renner O; Blanco-Aparicio C; Grassow M; Cañamero M; Leal JF; Carnero A
Cancer Res; 2008 Dec; 68(23):9643-53. PubMed ID: 19047141
[TBL] [Abstract][Full Text] [Related]
67. Hyperplastic and neoplastic changes in the mammary glands of feral mice free of endogenous mouse mammary tumor virus provirus.
Faulkin LJ; Mitchell DJ; Young LJ; Morris DW; Malone RW; Cardiff RD; Gardner MB
J Natl Cancer Inst; 1984 Oct; 73(4):971-82. PubMed ID: 6090752
[TBL] [Abstract][Full Text] [Related]
68. Keratinocyte growth factor induces mammary and prostatic hyperplasia and mammary adenocarcinoma in transgenic mice.
Kitsberg DI; Leder P
Oncogene; 1996 Dec; 13(12):2507-15. PubMed ID: 9000125
[TBL] [Abstract][Full Text] [Related]
69. Targeted expression of a dominant negative epidermal growth factor receptor in the mammary gland of transgenic mice inhibits pubertal mammary duct development.
Xie W; Paterson AJ; Chin E; Nabell LM; Kudlow JE
Mol Endocrinol; 1997 Nov; 11(12):1766-81. PubMed ID: 9369445
[TBL] [Abstract][Full Text] [Related]
70. The transcription factor ATF3 acts as an oncogene in mouse mammary tumorigenesis.
Wang A; Arantes S; Yan L; Kiguchi K; McArthur MJ; Sahin A; Thames HD; Aldaz CM; Macleod MC
BMC Cancer; 2008 Sep; 8():268. PubMed ID: 18808719
[TBL] [Abstract][Full Text] [Related]
71. Generation of a novel MMTV-tTA transgenic mouse strain for the targeted expression of genes in the embryonic and postnatal mammary gland.
Sakamoto K; Schmidt JW; Wagner KU
PLoS One; 2012; 7(8):e43778. PubMed ID: 22952764
[TBL] [Abstract][Full Text] [Related]
72. Cre-mediated gene deletion in the mammary gland.
Wagner KU; Wall RJ; St-Onge L; Gruss P; Wynshaw-Boris A; Garrett L; Li M; Furth PA; Hennighausen L
Nucleic Acids Res; 1997 Nov; 25(21):4323-30. PubMed ID: 9336464
[TBL] [Abstract][Full Text] [Related]
73. Morphology and progression of preneoplastic changes in methylcholanthrene-induced mouse mammary tumorigenesis.
Basolo F; Fontanini G; Squartini F
Tumori; 1985 Feb; 71(1):1-11. PubMed ID: 3984042
[TBL] [Abstract][Full Text] [Related]
74. Angiogenic acceleration of Neu induced mammary tumor progression and metastasis.
Oshima RG; Lesperance J; Munoz V; Hebbard L; Ranscht B; Sharan N; Muller WJ; Hauser CA; Cardiff RD
Cancer Res; 2004 Jan; 64(1):169-79. PubMed ID: 14729621
[TBL] [Abstract][Full Text] [Related]
75. The C3(1)/SV40 T-antigen transgenic mouse model of mammary cancer: ductal epithelial cell targeting with multistage progression to carcinoma.
Green JE; Shibata MA; Yoshidome K; Liu ML; Jorcyk C; Anver MR; Wigginton J; Wiltrout R; Shibata E; Kaczmarczyk S; Wang W; Liu ZY; Calvo A; Couldrey C
Oncogene; 2000 Feb; 19(8):1020-7. PubMed ID: 10713685
[TBL] [Abstract][Full Text] [Related]
76. [Comparison of background factors relevant to mammary tumorigenesis between DDD/1-Mtv-2/Mtv-2 congenic and DDD/1 mice].
Sayama K; Tanaka S; Matsuzawa A
Jikken Dobutsu; 1990 Oct; 39(4):583-8. PubMed ID: 2173665
[TBL] [Abstract][Full Text] [Related]
77. Neoplastic transformation of mouse mammary epithelial cells by in vitro exposure to N-methyl-N-nitrosourea.
Miyamoto S; Guzman RC; Osborn RC; Nandi S
Proc Natl Acad Sci U S A; 1988 Jan; 85(2):477-81. PubMed ID: 3422439
[TBL] [Abstract][Full Text] [Related]
78. Activated neu induces rapid tumor progression.
Guy CT; Cardiff RD; Muller WJ
J Biol Chem; 1996 Mar; 271(13):7673-8. PubMed ID: 8631805
[TBL] [Abstract][Full Text] [Related]
79. Hyperplasia of mouse mammary epithelium induced by expression of the Wnt-1 (int-1) oncogene in reconstituted mammary gland.
Edwards PA; Hiby SE; Papkoff J; Bradbury JM
Oncogene; 1992 Oct; 7(10):2041-51. PubMed ID: 1408145
[TBL] [Abstract][Full Text] [Related]
80. Conditional deletion of β-catenin in mammary epithelial cells of Ron receptor, Mst1r, overexpressing mice alters mammary tumorigenesis.
Wagh PK; Zinser GM; Gray JK; Shrestha A; Waltz SE
Endocrinology; 2012 Jun; 153(6):2735-46. PubMed ID: 22474186
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
